@prefix adms: <http://www.w3.org/ns/adms#> .
@prefix au: <http://www.w3.org/2015/03/inspire/au#> .
@prefix bc: <https://ontology.bommaritollc.com/vocab/core/> .
@prefix bcgeo: <https://ontology.bommaritollc.com/vocab/geo/> .
@prefix bcleg: <https://ontology.bommaritollc.com/vocab/leg/> .
@prefix bcorg: <https://ontology.bommaritollc.com/vocab/org/> .
@prefix bcsec: <https://ontology.bommaritollc.com/vocab/sec/> .
@prefix bcweb: <https://ontology.bommaritollc.com/vocab/web/> .
@prefix dcat: <http://www.w3.org/ns/dcat#> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix eli: <http://data.europa.eu/eli/ontology#> .
@prefix geo: <http://www.opengis.net/ont/geosparql#> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix opengov: <http://www.w3.org/ns/opengov#> .
@prefix org: <http://www.w3.org/ns/org#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix pav: <http://purl.org/pav/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix semapv: <https://w3id.org/semapv/vocab/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix skosxl: <http://www.w3.org/2008/05/skos-xl#> .
@prefix sssom: <https://w3id.org/sssom/> .
@prefix time: <http://www.w3.org/2006/time#> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://ontology.bommaritollc.com/id/01a135b5-98fc-7172-8570-e1d31460f31d> a oa:SpecificResource ;
    adms:identifier <https://ontology.bommaritollc.com/id/01a135b5-9905-73ac-b084-c818af8b9d2a> ;
    oa:bodyValue "{\"legal_state\":\"unknown\",\"passage\":{\"end_byte\":59781,\"instrument_iri\":\"https://ontology.bommaritollc.com/id/01a1359d-07cb-7618-8546-1808408536fa\",\"original_sha256\":\"1022dd1dc1574e2978d91da93ce298aace6da86532cfbca6606de47c52eb02c1\",\"parsed_text_sha256\":\"345432ee3c34113609615568036470f246bf683d4760f06eeba4416377a9875d\",\"source_url\":\"https://www.ag.ky.gov/Press%20Release%20Attachments/2024.01.09%20Kentucky_Kroger%20As%20Filed%20Consent%20Judgement.pdf\",\"start_byte\":47792},\"policy\":\"retained-legal-source-passage-v1\",\"quote\":\"change its Notice Designee(s) by giving written notice to all other Parties as provided in this\\n\\ndelivered to the persons\\n\\ndelivery or registered or\\n\\nparagraph.\\n\\n1.\\n\\n2.\\n\\nspecified below (“Notice Designees”)\\n\\ncertified mail, return receipt required, postage pre\\n\\nNotices to the Commonwealth shall be\\n\\nRobert Duncan\\n\\nDeputy Attorney General\\n\\nOffice of the Kentucky Attorney General\\n\\n700 Capital Avenue, Suite 118\\n\\nFrankfort, Kentucky 40601\\n\\nEmail: robertm.duncan@ky.gov\\n\\nAND\\n\\nChris Lewis\\n\\nDivision Chief\\n\\nOffice of the Kentucky Attorney General\\n\\n1024 Capital Center Drive, Suite 200\\n\\nFrankfort, Kentucky 40601\\n\\nEmail: christian.lewis@ky.gov\\n\\nAND\\n\\nLinda Singer\\n\\nMotleyRice LLC\\n\\n401 9th St. NW, Suite 630\\n\\nWashington, DC 20004\\n\\nEmail: lsinger@motleyrice.com\\n\\nNoticesto Kroger shall be delivered to:\\n\\nAntonio Matthews\\n\\nSenior Litigation Counsel\\n\\n1014 Vine St.\\n\\nCincinnati, Ohio, 45202\\n\\nTelephone: (513) 762-4623\\n\\nEmail: toney.matthews@kroger.com\\n\\nAND\\n\\nChantale Fiebig\\n\\nWeil Gotshal & Manges LLP\\n\\n2001 M Street, NW\\n\\nWashington, D.C. 20036\\n\\nTelephone: (202) 682-7200\\n\\n9\\n\\n(i) by email or (ii) by either hand\\n\\nB45F664A-03E5-4F6A-9B6C-86F80E8B6E3B : 000022 of 000064\\n\\n-\\n\\n-paid. Any Party may\\n\\ndelivered to:\\n\\nEmail: chantale.fiebig@weil.com\\n\\nB45F664A-03E5-4F6A-9B6C-86F80E8B6E3B : 000023 of 000064\\n\\nI. Severability; Reinstatement. In the event any one or more immaterial\\n\\nprovisions of this Settlement shall for any reason be held to be invalid, illegal, or unenforceable\\n\\nin any respect, such invalidity, illegality, or unenforceability shall not affect any other\\n\\nprovision of this Settlement. Material provisions are those in Sections III, IV, VI, and VII of\\n\\nthis Agreement.\\n\\nJ. Headings; Definitions. The headings used in this Agreement are intended for the\\n\\nconvenience of the reader only and shall not affect the meaning or interpretation of this Agreement.\\n\\nThe definitions contained in this Agreement or any Exhibit hereto are applicable to the singular as\\n\\nwell as the plural forms of such terms.\\n\\nK. No Party Deemed to Be the Drafter. None of the Parties hereto shall be deemed\\n\\nto be the drafter of this Agreement or any provision hereof for the purpose of any statute, case law,\\n\\nor rule of interpretation or construction that would or might cause any provision to be construed\\n\\nagainst the drafter.\\n\\nL. Modification. This Agreement may only be modified by a written agreement of\\n\\nthe Parties or, in the case of the Consent Judgment(s), by court proceedings resulting in a modified\\n\\njudgment of a court of competent jurisdiction. For purposes of modifying this Agreement or the\\n\\nConsent Judgment(s), Kroger may contact the Kentucky Attorney General for purposes of\\n\\ncoordinating this process. Modifications must be in writing to be enforceable.\\n\\nM. Waiver. Any failure by any Party to this Agreement to insist upon the strict\\n\\nperformance by any other Party of any of the provisions of this Agreement shall not be deemed a\\n\\nwaiver of any of the provisions of this Agreement, and such Party, notwithstanding such failure,\\n\\nshall have the right thereafter to insist upon the specific performance of any and all of the\\n\\nprovisions of this Agreement.\\n\\nN. Execution in Counterparts. This Agreement may be executed in one or more\\n\\ncounterparts. All executed counterparts and each of them shall be deemed to be one and the same\\n\\ninstrument. An executed signature page of this Settlement delivered in PDF format via email shall\\n\\nbe as effective as an original executed signature page.\\n\\nO. Integrated Agreement. This Agreement constitutes the entire agreement between\\n\\nthe Parties and no representations, warranties, or inducements have been made to any Party\\n\\nconcerning this Agreement other than the representations, warranties, and covenants contained and\\n\\nmemorialized herein. As such, the Parties represent and warrant that they are not relying on any\\n\\npromises, inducements, or representations other than those provided herein.\\n\\nP. Confidentiality and Public Statements. Consistent with mediation\\n\\nconfidentiality, neither party shall disclose or discussthe negotiating positionsthe parties advanced\\n\\nduring discussions in connection with this Settlement Agreement. In addition, and for the\\n\\navoidance of doubt, neither party shall discuss the negotiation of specific terms and conditions of\\n\\nthis Settlement Agreement. All terms relating to this Settlement Agreement will remain\\n\\nconfidential until after the Multistate Effective Date, except as permitted by Section III.D, and\\n\\nneither party will issue any press release or public statement regarding this Settlement Agreement\\n\\n10\\n\\nor the Settlement Amount before the Multistate Effective Date.\\n\\nIN WITNESS WHEREOF, the Parties\\n\\nrepresentatives, have executed this Agreement\\n\\nDate: October 31, 2024\\n\\nDate:\\n\\nB45F664A-03E5-4F6A-9B6C-86F80E8B6E3B : 000024 of 000064\\n\\nhereto, through their fully authorized\\n\\nas of the dates set forth below.\\n\\nTHE KROGER CO.\\n\\nBy:\\n\\nWEIL GOTSHAL & MANGES LLP\\n\\nChantale Fiebig\\n\\n2001 M Street, NW\\n\\nWashington, D.C. 20036\\n\\nTelephone: (202) 682-7200\\n\\nEmail: chantale.fiebig@weil.com\\n\\nTHE COMMONWEALTH OF KENTUCKY\\n\\nBy:\\n\\nName: Russell Coleman\\n\\nTitle: Attorney General\\n\\n11\\n\\nAs used in this Schedule A, words like “expand,” “fund,” “provide” or the like shall not indicate a preference for\\n\\nabatement strategies (“\\n\\n1\\n\\nnew or existing programs.\\n\\nA.\\n\\nB.\\n\\nabatement strategies listed in Schedule B. However, priority may be given to the\\n\\nSettling States and Participating Subdivisions listed on Exhibit G may choose from among the\\n\\nEXHIBIT E\\n\\nB45F664A-03E5-4F6A-9B6C-86F80E8B6E3B : 000025 of 000064\\n\\nList of Opioid Remediation Uses\\n\\nSchedule A\\n\\nCore Strategies\\n\\nfollowing core\\n\\nCore Strategies”).1\\n\\nNALOXONE OR OTHER FDA-APPROVED DRUG TO\\n\\nREVERSE OPIOID OVERDOSES\\n\\n1. Expand training for first responders, schools, community\\n\\nsupport groups and families; and\\n\\n2. Increase distribution to individuals who are uninsured or\\n\\nwhose insurance does not cover the needed service.\\n\\nMEDICATION-ASSISTED TREATMENT (“MAT”T”)\\n\\nDISTRIBUTION AND OTHER OPIOID-RELATED\\n\\nTREATMENT\\n\\n1. Increase distribution of MAT to individuals who are\\n\\nuninsured or whose insurance does not cover the needed\\n\\nservice;\\n\\n2. Provide education to school-based and youth-focused\\n\\nprograms that discourage or prevent misuse;\\n\\n3. Provide MAT education and awareness training to\\n\\nhealthcare providers, EMTs, law enforcement, and other\\n\\nfirst responders; and\\n\\n4. Provide treatment and recovery support services such as\\n\\nresidential and inpatient treatment, intensive outpatient\\n\\ntreatment, outpatient therapy or counseling, and recovery\\n\\nhousing that allow or integrate medication and with other\\n\\nsupport services.\\n\\nE-1\\n\\nExpand services for better continuum of care with infant\\n\\nEXPANDING TREATMENT FOR NEONATAL\\n\\nfor uninsured individuals for up to 12 months postpartum;\\n\\nrecovery services, including MAT, for women with co\\n\\nExpand Screening, Brief Intervention, and Referral to\\n\\nC.\\n\\nD.\\n\\nE.\\n\\nPREGNANT & POSTPARTUM WOMEN\\n\\nB45F664A-03E5-4F6A-9B6C-86F80E8B6E3B : 000026 of 000064\\n\\n1.\\n\\nTreatment (“SBIRT”T”) services to non-Medicaid eligible or\\n\\nuninsured pregnant women;\\n\\n2. Expand comprehensive evidence-based treatment and\\n\\n\\u0002\\n\\noccurring Opioid Use Disorder (“OUD”) and other\\n\\nSubstance Use Disorder (“SUD”)/Mental Health disorders\\n\\nand\\n\\n3. Provide comprehensive wrap-around services to individuals\\n\\nwith OUD, including housing, transportation, job\\n\\nplacement/training, and childcare.\\n\\nABSTINENCE SYNDROME (“NAS”)\\n\\n1. Expand comprehensive evidence-based and recovery\\n\\nsupport for NAS babies;\\n\\n2. \\u0002\\n\\nneed dyad; and\\n\\n3. Expand long-term treatment and services for medical\\n\\nmonitoring of NAS babies and their families.\\n\\nEXPANSION OF WARM HAND-OFF PROGRAMS AND\\n\\nRECOVERY SERVICES\\n\\n1. Expand services such as navigators and on-call teams to\\n\\nbegin MAT in hospital emergency departments;\\n\\n2. Expand warm hand-off services to transition to recovery\\n\\nservices;\\n\\n3. Broaden scope of recovery services to include co-occurring\\n\\nSUD or mental health conditions;\\n\\n4. Provide comprehensive wrap-around services to individuals\\n\\nin recovery, including housing, transportation, job\\n\\nplacement/training, and childcare; and\\n\\nE-2\\n\\nABATEMENT STRATEGIES WITHIN THE STATE\\n\\nRESEARCH ANALYZING THE EFFECTIVENESS OF THE\\n\\ntreatment, access to sterile syringes and linkage to care and\\n\\nProvide comprehensive syringe services programs with\\n\\nEXPANDING SYRINGE SERVICE PROGRAMS\\n\\nFunding and training for first responders to participate in pre\\n\\nguidelines, including providers at hospitals (academic\\n\\nbest prescribing practices for opioids consistent with the CDC\\n\\nFunding for medical provider education and outreach regarding\\n\\nthe FDA’s “Real Cost” campaign to prevent youth from\\n\\nFunding for media campaigns to prevent opioid use (similar to\\n\\nIncrease funding for jails to provide treatment to inmates\\n\\nSUD/MH disorders within and transitioning out of the\\n\\nF.\\n\\nG.\\n\\nH.\\n\\nI.\\n\\nTREATMENT FOR INCARCERATED POPULATION\\n\\n5.\\n\\nB45F664A-03E5-4F6A-9B6C-86F80E8B6E3B : 000027 of 000064\\n\\nworkers to facilitate expansions above.\\n\\n1. Provide evidence-based treatment and recovery support,\\n\\nincluding MAT for persons with OUD and co-occurring\\n\\ncriminal justice system; and\\n\\n2.\\n\\nwith OUD.\\n\\nPREVENTION PROGRAMS\\n\\n1.\\n\\nmisusing tobacco);\\n\\n2. Funding for evidence-based prevention programs in schools;\\n\\n3.\\n\\ndetailing);\\n\\n4. Funding for community drug disposal programs; and\\n\\n5. \\u0002\\n\\narrest diversion programs, post-overdose response teams, or\\n\\nsimilar strategies that connect at-risk individuals to behavioral\\n\\nhealth services and supports.\\n\\n1.\\n\\nmore wrap-around services, including linkage to OUD\\n\\ntreatment of infectious diseases.\\n\\nEVIDENCE-BASED DATA COLLECTION AND\\n\\nE-3\\n\\nHire additional social workers or other behavioral health\\n\\nSchedule B\\n\\nB45F664A-03E5-4F6A-9B6C-86F80E8B6E3B : 000028 of 000064\\n\\nApproved Uses\\n\\nSupport treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use Disorder\\n\\nor Mental Health (SUD/MH) conditions through evidence-based or evidence-informed programs\\n\\nor strategies that may include, but are not limited to, the following:\\n\\nPART ONE: TREATMENT\\n\\nA. TREAT OPIOID USE DISORDER (OUD)\\n\\nSupport treatment of Opioid Use Disorder (“OUD”) and any co-occurring Substance Use\\n\\nDisorder or Mental Health (“SUD/MH”H”) conditions through evidence-based or evidence\\u0002\\n\\ninformed programs or strategies that may include, but are not limited to, those that:2\\n\\n1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions,\\n\\nincluding all forms of Medication-Assisted Treatment (“M“MAT”T”) approved by the U.S.\\n\\nFood and Drug Administration.\\n\\n2. Support and reimburse evidence-based services that adhere to the American Society\\n\\nof Addiction Medicine (“A“ASAM”M”) continuum of care for OUD and any co-occurring\\n\\nSUD/MH conditions.\\n\\n3. Expand telehealth to increase access to treatment for OUD and any co-occurring\\n\\nSUD/MH conditions, including MAT, as well as counseling, psychiatric support, and\\n\\nother treatment and recovery support services.\\n\\n4. Improve oversight of Opioid Treatment Programs (“OTPs”) to assure evidence-based\\n\\nor evidence-informed practices such as adequate methadone dosing and low threshold\\n\\napproaches to treatment.\\n\\n5. Support mobile intervention, treatment, and recovery services, offered by qualified\\n\\nprofessionals and service providers, such as peer recovery coaches, for persons with\\n\\nOUD and any co-occurring SUD/MH conditions and for persons who have\\n\\nexperienced an opioid overdose.\\n\\n6. Provide treatment of trauma for individuals with OUD (e.g., violence, sexual assault,\\n\\nhuman trafficking, or adverse childhood experiences) and family members (e.g.,\\n\\nsurviving family members after an overdose or overdose fatality), and training of\\n\\nhealth care personnel to identify and address such trauma.\\n\\n2 As used in this Schedule B, words like “expand,” “fund,” “provide” or the like shall not indicate a preference for\\n\\nnew or existing programs.\\n\\nE-4\\n\\n\",\"statutory_number\":null,\"whole_instrument_recall\":\"not_established\"}"^^rdf:JSON ;
    oa:hasSource <https://www.ag.ky.gov/Press%20Release%20Attachments/2024.01.09%20Kentucky_Kroger%20As%20Filed%20Consent%20Judgement.pdf> ;
    prov:wasDerivedFrom <https://ontology.bommaritollc.com/id/01a135b5-98fc-7172-8570-e1d21c078be7> ;
    schema:isPartOf <https://ontology.bommaritollc.com/id/01a1359d-07cb-7618-8546-1808408536fa> .
